0001140361-21-024128.txt : 20210713 0001140361-21-024128.hdr.sgml : 20210713 20210712191652 ACCESSION NUMBER: 0001140361-21-024128 CONFORMED SUBMISSION TYPE: 15-12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210713 DATE AS OF CHANGE: 20210712 EFFECTIVENESS DATE: 20210713 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PRA Health Sciences, Inc. CENTRAL INDEX KEY: 0001613859 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 463640387 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-36732 FILM NUMBER: 211086445 BUSINESS ADDRESS: STREET 1: 4130 PARKLAKE AVENUE STREET 2: SUITE 400 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 9197868200 MAIL ADDRESS: STREET 1: 4130 PARKLAKE AVENUE STREET 2: SUITE 400 CITY: RALEIGH STATE: NC ZIP: 27612 15-12B 1 brhc10026804_1512b.htm 15-12B
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-36732
  
PRA HEALTH SCIENCES, INC.
(Exact name of registrant as specified in its charter)
 
4130 ParkLake Avenue
Suite 400
Raleigh, NC 27612
(919) 786-8200
 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
Common Stock, $0.01 par value per share
(Title of each class of securities covered by this Form)
 
N/A
 (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
 
Rule 12g-4(a)(1)
☒
 
Rule 12g-4(a)(2)
 ☐
 
Rule 12h-3(b)(1)(i)
 ☒
 
Rule 12h-3(b)(1)(ii)
 ☐
 
Rule 15d-6
 ☐
 
Rule 15d-22(b)
☐
 
Approximate number of holders of record as of the certification or notice date: Two

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, PRA Health Sciences, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

PRA Health Sciences, Inc.




Date:
July 12, 2021
By:
/s/ Brendan Brennan




Name:
Brendan Brennan




Title:
Chief Financial Officer